NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
36 hedge funds and large institutions have $287K invested in Nymox Pharmaceutical Corp in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
50% less capital invested
Capital invested by funds: $575K → $287K (-$288K)
Holders
36
Holding in Top 10
–
Calls
$1K
Puts
$1K
Top Buyers
| 1 | +$14.3K | |
| 2 | +$6.49K | |
| 3 | +$2.13K | |
| 4 |
VF
Virtu Financial
New York
|
+$1.39K |
| 5 |
JPMorgan Chase & Co
New York
|
+$470 |
Top Sellers
| 1 | -$28.5K | |
| 2 | -$18.4K | |
| 3 | -$16K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$1.82K |